In this interview we discuss the CRISPR technology currently being used to “edit” genes and when we might see the technology in mainstream practice.
Ji Luo, PhD
Advertisement
Articles by Ji Luo, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Sunvozertinib Improves PFS vs Chemotherapy in EGFR+ NSCLC
2
Considering Venlafaxine as Distress Treatment in Breast Cancer
3
The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes
4
Nogapendekin Alfa/BCG BLA Resubmitted for NMIBC Population
5